T2* MRI in Regularly Transfused Children with Thalassemia Intermedia: Serum Ferritin Does Not Reflect Liver Iron Stores

REFERENCES

• Olivieri NF. The β-thalassemias. N Engl J Med. 1999;341:99–109.
   PubMed Web of Science ®Google Scholar
• Taher A, Musallam KM, Karimi M, Overview of practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the optimal care study. Blood. 2010;115(10):1886–1892.
   PubMed Web of Science ®Google Scholar
• Gardenghi S, Ramos P, Follenzi A, Hepcidin and Hfe in iron overload in beta thalassemia. Ann N Y Acad Sci. 2010;1202:221–225.
   PubMed Web of Science ®Google Scholar
• Anderson LJ, Holden S, Davis B, Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171–2179.
   PubMed Web of Science ®Google Scholar
• Taher A, Ismaeel H, Cappellini MD. Thalassaemia intermedia: revisited. Blood Cells Mol Dis. 2006;37(1):12–20.
   PubMed Web of Science ®Google Scholar
• Nemeth E. Hepcidin in beta-thalassemia. Ann N Y Acad Sci. 2010;1202:31–35.
   PubMed Web of Science ®Google Scholar
• Kearney SL, Nemeth E, Neufeld EJ, Urinary hepcidin in congenital chronic anemias. Pediatr Blood Cancer. 2007;48(1):57–63.
   PubMed Web of Science ®Google Scholar
• Origa R, Galanello R, Ganz T, Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica. 2007;92(5):583–588.
   PubMed Web of Science ®Google Scholar
• Cappellini MD, Cohen A, Eleftheriou A, Guidelines for the Clinical Management of Thalassaemia. 2nd rev.ed. Nicosia, Cyprus: Thalassaemia International Federation; 2008.
   Google Scholar
• Aessopos A, Farmakis D, Deftereos S, Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia. Chest. 2005;127(5):1523–1530.
   PubMed Web of Science ®Google Scholar
• Isma'eel H, Chafic AH, Rassi FE, Relation between iron-overload indices, cardiac echo-Doppler and biochemical markers in thalassemia intermedia. Am J Cardiol. 2008;102(3):363–367.
   PubMed Web of Science ®Google Scholar
• Borgna-Pignatti C, Marsella M, Zanforlin N. The natural history of thalassemia intermedia. Ann N Y Acad Sci. 2010;1202:214–220.
   PubMed Web of Science ®Google Scholar
• Westwood M, Anderson LJ, Firmin DN, A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging. 2003;18(1):33–39.
   PubMed Web of Science ®Google Scholar
• Phylipsen M, Prior JF, Lim E, Two new alpha1-globin gene point mutations: Hb Nedlands (HBA1:c.86C>T) [alpha28(B9)Ala–>Val] and Hb Queens Park (HBA1:c.98T>A) [alpha32(B13)Met–>Lys]. Hemoglobin. 2010;34(2):123–126.
   PubMed Web of Science ®Google Scholar
• Laosombat V, Viprakasit V, Chotsampancharoen T, Clinical features and molecular analysis in Thai patients with HbH disease. Ann Hematol. 2009;88(12):1185–1192.
   PubMed Web of Science ®Google Scholar
• dos Santos CO, Zhou S, Secolin R, Population analysis of the alpha hemoglobin stabilizing protein (AHSP) gene identifies sequence variants that alter expression and function. Am J Hematol. 2008;83(2):103–108.
   PubMed Web of Science ®Google Scholar
• So CC, So AC, Chan AY, Detection and characterisation of beta-globin gene cluster deletions in Chinese using multiplex ligation-dependent probe amplification. J Clin Pathol. 2009;62(12):1107–1111.
   PubMed Web of Science ®Google Scholar
• Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102(3):783–788.
   PubMed Web of Science ®Google Scholar
• Gardenghi S, Grady RW, Rivella S. Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia. Hematol Oncol Clin North Am. 2010;24(6):1089–1107.
   PubMed Web of Science ®Google Scholar
• Pakbaz Z, Fischer R, Fung E, Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients. Pediatr Blood Cancer. 2007;49(3):329–332.
   PubMed Web of Science ®Google Scholar
• Olthof AW, Sijens PE, Kreeftenberg HG, Correlation between serum ferritin levels and liver iron concentration determined by MR imaging: impact of hematologic disease and inflammation. Magn Reson Imaging 2007;25(2):228–231.
   PubMed Web of Science ®Google Scholar
• Nielsen P, Günther U, Dürken M, Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance. J Lab Clin Med. 2000;135(5):413–418.
   PubMed Web of Science ®Google Scholar
• Tanno T, Bhanu NV, Oneal PA, High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med. 2007;13(9):1096–1101.
   PubMed Web of Science ®Google Scholar
• Finkenstedt A, Bianchi P, Theurl I, Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency. Br J Hematol. 2009;144(5):789–793.
   PubMed Web of Science ®Google Scholar
• Wali Y, Al Zadjali S, Elshinawy M, Severity ranking of non-deletional alpha thalassemic alleles: insights from an Omani family study. Eur J Haematol. 2011;86(6):507–511.
   PubMed Web of Science ®Google Scholar
• Roghi A, Cappellini MD, Wood JC, Absence of cardiac siderosis despite hepatic iron overload in Italian patients with thalassemia intermedia: an MRI T2* study. Ann Hematol. 2010;89(6):585–589.
   PubMed Web of Science ®Google Scholar
• Origa R, Barella S, Argiolas GM, No evidence of cardiac iron in 20 never- or minimally-transfused patients with thalassemia intermedia. Haematologica. 2008;93(7):1095–1096.
   PubMed Web of Science ®Google Scholar
• Jensen PD, Jensen FT, Christensen T, Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood. 2003;101:4632–4639.
   PubMed Web of Science ®Google Scholar